Scientists use multi-day live cell assays to monitor cell growth, viability, and cytotoxicity when evaluating the effects of drug treatment. However, maintaining consistent cell health over time ...

TarSeer™ BRETSA™ Target Engagement System enables studies for difficult proteins early in drug discoveryPromega UK, Southampton, UK. (10 February 2026) Promega Corporation is launching a new live-cell ...

This article is based on a poster originally authored by Yongyang Huang, Ning Guo, Mackenzie Pierce, Leo Chan, Bo Lin and Yi Yang, which was presented at ELRIG Drug Discovery 2024 in affiliation with ...

Promega Corporation has introduced a new platform designed to help drug discovery scientists study some of the most challenging protein targets in living cells, enabling earlier and more reliable ...

In the ever-evolving landscape of biomedical research, the need for reliable, consistent, and ready-to-use cell models has never been more critical. ATCC, a leading provider of biological materials, ...

In the immuno-oncology field, scientists discover, test, and validate novel immunotherapeutic agents that leverage the human immune system to fight cancer, such as checkpoint inhibitors, vaccine-based ...

Creation of an end-to-end antibody engine: rapid discovery paired with physiologically relevant translational assays to confirm MoA early and de-risk IND readiness.Motherwell, Scotland, [17] February ...

Products released at this year's meeting covered a broad range of applications from sustainable labware to protein assays to instruments.

Discover effective protein quantification methods for precision in molecular biology and clinical diagnostics.